Yingyan Lu

520 total citations
11 papers, 97 citations indexed

About

Yingyan Lu is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Yingyan Lu has authored 11 papers receiving a total of 97 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Hepatology and 4 papers in Surgery. Recurrent topics in Yingyan Lu's work include Liver Disease Diagnosis and Treatment (5 papers), Liver Disease and Transplantation (3 papers) and Liver physiology and pathology (3 papers). Yingyan Lu is often cited by papers focused on Liver Disease Diagnosis and Treatment (5 papers), Liver Disease and Transplantation (3 papers) and Liver physiology and pathology (3 papers). Yingyan Lu collaborates with scholars based in China, United States and United Kingdom. Yingyan Lu's co-authors include ­Jun Li­, Jiacheng Li, Kequn Chai, Guanping Chen, Jing Li, Qun Li, Yifan Wang, Mingqian Li, Qinsong Sheng and Jiaojiao Xin and has published in prestigious journals such as Biochemical and Biophysical Research Communications, The Journal of Infectious Diseases and BMC Medicine.

In The Last Decade

Yingyan Lu

11 papers receiving 95 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingyan Lu China 7 40 34 33 21 16 11 97
Xiliu Chen China 4 38 0.9× 27 0.8× 27 0.8× 11 0.5× 2 0.1× 5 82
Ziwei Guo China 7 70 1.8× 10 0.3× 42 1.3× 11 0.5× 27 1.7× 13 151
Dinesh Velayutham Qatar 8 54 1.4× 11 0.3× 15 0.5× 7 0.3× 37 2.3× 18 114
Nobuyo Higashi Japan 8 77 1.9× 86 2.5× 64 1.9× 34 1.6× 9 0.6× 14 170
Weimin Wang China 7 47 1.2× 29 0.9× 32 1.0× 9 0.4× 7 0.4× 13 126
Eun Uk Jung South Korea 9 97 2.4× 100 2.9× 94 2.8× 6 0.3× 5 0.3× 20 212
Ipsita Mohanty United States 3 66 1.6× 18 0.5× 31 0.9× 30 1.4× 10 0.6× 4 143
Haoliang Wang China 8 32 0.8× 86 2.5× 116 3.5× 26 1.2× 6 0.4× 13 202
Imogen Morris Netherlands 4 31 0.8× 14 0.4× 36 1.1× 22 1.0× 4 0.3× 6 89
Yunan Wu China 3 30 0.8× 18 0.5× 18 0.5× 8 0.4× 2 0.1× 4 88

Countries citing papers authored by Yingyan Lu

Since Specialization
Citations

This map shows the geographic impact of Yingyan Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingyan Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingyan Lu more than expected).

Fields of papers citing papers by Yingyan Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingyan Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingyan Lu. The network helps show where Yingyan Lu may publish in the future.

Co-authorship network of co-authors of Yingyan Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Yingyan Lu. A scholar is included among the top collaborators of Yingyan Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingyan Lu. Yingyan Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Wang, Lu, Yu Chen, Ying Li, et al.. (2025). Polyphyllin I enhances the anti-tumor efficacy of Palbociclib by reversing M2 macrophage polarization in lung cancer. Biochemical and Biophysical Research Communications. 777. 152228–152228. 1 indexed citations
2.
Lu, Yingyan, et al.. (2025). Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system. BMC Pharmacology and Toxicology. 26(1). 129–129. 1 indexed citations
3.
Lu, Yingyan, Jiaojiao Xin, Xi Liang, et al.. (2024). Plasma MERTK Is a Promising Biomarker for the Diagnosis and Prognosis of Hepatitis B Virus–Related Acute-on-Chronic Liver Failure. The Journal of Infectious Diseases. 230(4). 957–969. 1 indexed citations
4.
Hassan, Hozeifa Mohamed, Xi Liang, Jiaojiao Xin, et al.. (2024). Thrombospondin 1 enhances systemic inflammation and disease severity in acute-on-chronic liver failure. BMC Medicine. 22(1). 95–95. 9 indexed citations
5.
Liang, Xi, Jiaojiao Xin, Peng Li, et al.. (2022). Serum ferritin diagnosis and prediction of hepatitis B virus‐related acute‐on‐chronic liver failure. Journal of Medical Virology. 95(1). e28183–e28183. 7 indexed citations
6.
Hassan, Hozeifa Mohamed, Qun Cai, Xi Liang, et al.. (2021). Transcriptomics reveals immune-metabolism disorder in acute-on-chronic liver failure in rats. Life Science Alliance. 5(3). e202101189–e202101189. 12 indexed citations
7.
Sheng, Qinsong, Fei Li, Guanping Chen, et al.. (2021). Ursolic Acid Regulates Intestinal Microbiota and Inflammatory Cell Infiltration to Prevent Ulcerative Colitis. Journal of Immunology Research. 2021. 1–16. 39 indexed citations
8.
Shi, Dongyan, Jiaojiao Xin, Yingyan Lu, et al.. (2020). Transcriptome Profiling Reveals Distinct Phenotype of Human Bone Marrow Mesenchymal Stem Cell-derived Hepatocyte-like cells. International Journal of Medical Sciences. 17(2). 263–273. 10 indexed citations
9.
10.
Guo, Jing, ­Jun Li­, Yingyan Lu, et al.. (2011). A Novel Technique for Hepatic Progenitor Cell Isolation From Normal Adult Rat Livers. ASAIO Journal. 58(1). 73–78. 7 indexed citations
11.
Sheng, Jifang, et al.. (2006). Cloning and expression of the human augmenter of liver regeneration at low temperature in Escherichia coli. Journal of Biochemical and Biophysical Methods. 70(3). 465–470. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiliu Chen Breakdown of academic impact, for papers by Ziwei Guo Breakdown of academic impact, for papers by Dinesh Velayutham Breakdown of academic impact, for papers by Nobuyo Higashi Breakdown of academic impact, for papers by Weimin Wang Breakdown of academic impact, for papers by Eun Uk Jung Breakdown of academic impact, for papers by Ipsita Mohanty Breakdown of academic impact, for papers by Haoliang Wang Breakdown of academic impact, for papers by Imogen Morris Breakdown of academic impact, for papers by Yunan Wu
Rankless by CCL
2026